Search
Oxolamine
go.drugbank.com/drugs/DB13216ApprovedOxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant [L5416]. It is listed as a prescription drug in New Zealand legislation [L5419]. … Oxolamine is also approved in Taiwan for the treatment of respiratory tract inflamation [L5422].
Mixtures: KATARIN FORT 650 MG/200 MG/60 MG/4 MG FİLM KAPLI TABLET, 20 ADET, OLEDRO HOT D TEK DOZLUK EFERVESAN GRANÜL İÇEREN POŞET, 6 ADETCategories: Heterocyclic Compounds, 1-RingNADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
go.drugbank.com/bio_entities/BE0000213TargetHumansAccessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly (PubMed:30245030). Complex I functions in the tran...
Polypeptides: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6Synonyms: LYR motif-containing protein 66-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1
go.drugbank.com/bio_entities/BE0001073TargetEnzymeHumansSynthesis and degradation of fructose 2,6-bisphosphate
Polypeptides: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1Function: 6-phosphofructo-2-kinase activity3-keto-L-gulonate-6-phosphate decarboxylase UlaD
go.drugbank.com/bio_entities/BE0001250TargetEscherichia coli (strain K12)Catalyzes the decarboxylation of 3-keto-L-gulonate-6-P into L-xylulose-5-P. Is involved in the anaerobic L-ascorbate utilization.
Polypeptides: 3-keto-L-gulonate-6-phosphate decarboxylase UlaDSynonyms: 3-dehydro-L-gulonate-6-phosphate decarboxylaseATP-binding cassette sub-family C member 6
go.drugbank.com/bio_entities/BE0003640TransporterTargetHumansATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of glutathione conjugates such as leukotriene-c4 (LTC4) and N...
Polypeptides: ATP-binding cassette sub-family C member 6Synonyms: Multidrug resistance-associated protein 6Dual specificity mitogen-activated protein kinase kinase 6
go.drugbank.com/bio_entities/BE0009461TargetHumansThe pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription.
Polypeptides: Dual specificity mitogen-activated protein kinase kinase 6Synonyms: MEK 6, MAPKK 6Cetirizine
go.drugbank.com/drugs/DB00341ApprovedInvestigationalOne of the most common uses for this drug is for a condition called _allergic rhinitis_. … The prevalence of allergic rhinitis in the United States is about 15% according to physician diagnoses, and up to 30%, according to self-reported nasal symptoms.
Mixtures: ACERADOX® G, GRIPAC 4®Categories: P-glycoprotein inhibitors, P-glycoprotein substratesRabeprazole
go.drugbank.com/drugs/DB01129ApprovedInvestigationalRabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. … Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
Mixtures: RASOFORCE 20/1680 MG TOZ İÇEREN SAŞE, 14 SAŞE, RABEDIC 10/75 MG MR KAPSÜL, 20 ADETCategories: Cytochrome P-450 Substrates, 2-PyridinylmethylsulfinylbenzimidazolesIpratropium
go.drugbank.com/drugs/DB00332ApprovedInvestigational[A176939] It is commonly administered through inhalation which allows producing a local effect without presenting a significant systemic absorption. … [A176957] Ipratropium as a therapeutic agent was developed by Boehringer Ingelheim and its first monotherapy product was FDA approved in 1986, while the combination product of ipratropium and [albuterol
Mixtures: NASOVİNE DUO 0,5 MG + 0,6 MG/ML BURUN SPREYİ, ÇÖZELTİ, 1 ADET, SALBUTAMOLO E IPRATROPIO BROMURO EGProducts: ATROVENT 500 MG /2ML, Nasipral 0,3 mg/ml Nasenspray, LösungEscitalopram
go.drugbank.com/drugs/DB01175ApprovedInvestigationalEscitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram]. … that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.
Synonyms: (S)-Citalopram, S(+)-CitalopramCategories: P-glycoprotein substrates, Cytochrome P-450 Substrates